- Home
- A-Z Publications
- Coronaviruses
- Fast Track Listing
Coronaviruses - Online First
Description text for Online First listing goes here...
1 - 20 of 38 results
-
-
COVID 19: Variants, Diagnosis and Vaccines- An Update
Authors: Parul Chauhan, Ankita Tiwari, Okoro Emmanuel and M. Arockia BabuAvailable online: 30 December 2024More LessIn 2019, a life-threatening virus, SARS-Cov 2 emerged in China and caused destruction all around the world, affecting many lives; the origin of this virus is still debatable and unclear. The coronavirus is a contagious disease with high rates of transmission; it mutates rapidly and now has variants, some of which have caused a lot of damage to lives and the economy. These variants are mainly classified into three main groups: a) variants of concern; b) variants of interest; and c) variants under monitoring. Vaccines are the safest and most effective option for preventing covid and saving lives, as building immunity and breaking the chain of transmission is essential even though vaccines that have been developed till now have different effects against different variants of coronavirus. As it is known that vaccines are the main shield to protect from coronavirus, due to rapid mutation and slow developments of vaccines several people are still getting infected with covid-19. Many treatment options are available, such as antiviral drugs, nanotechnology, plasma therapy, and monoclonal antibodies. Besides prevention and treatment, correct diagnosis of the disease is essential, and for this purpose, different diagnostic techniques are discussed in this article alongside the possible future of COVID-19.
-
-
-
The Association Between COVID-19 Vaccination Among Pregnant Women and Neonatal Outcomes: A Systematic Review and Meta-Analysis
Available online: 30 December 2024More LessBackground and AimLimited data exist regarding the safety of COVID-19 vaccines during pregnancy. Despite some studies supporting vaccine safety and efficacy in pregnant women, hesitancy persists. Hence, this study aims to evaluate vaccination effects on pregnancy and neonatal outcomes in vaccinated pregnant women compared to unvaccinated controls.
MethodsWe conducted a comprehensive literature search in databases including PubMed, Web of Science, and Scopus without any time restrictions up to September 2023. We used specific Medical Subject Headings (MeSH) terms and keywords related to COVID-19, pregnancy, neonatal outcomes, and vaccination. Studies without control groups, lacking neonatal outcome data, or not in English were excluded. Data on preterm births, small for gestational age, NICU admissions, low APGAR scores, and low birth weights were extracted and analyzed using statistical methods to pool odds ratios and assess heterogeneity and publication bias.
ResultsFinally, 27 studies were included in our final analysis. Vaccinated mothers exhibited a lower prevalence of preterm birth, with a pooled OR of 0.78 (95% CI: 0.70, 0.87, p-value < 0.01). No significant difference was found in the prevalence of SGA between the two groups, with a pooled OR of 0.99 (95% CI: 0.92, 1.07, p-value = 0.77). There was no significant difference in NICU admissions between the two groups, with a pooled OR of 0.89 (95% CI: 0.60, 1.32, p-value = 0.57). Conversely, unvaccinated mothers had a significantly higher prevalence of low 5-minute APGAR scores, with a pooled OR of 0.84 (95% CI: 0.72, 0.98, p-value = 0.02), and low birth weight, with a pooled OR of 0.83 (95% CI: 0.70, 0.97, p-value = 0.02).
ConclusionOur results demonstrated a significant decrease in the odds ratio of preterm birth, low birth weight, and low APGAR scores among those who received COVID-19 vaccination. However, we did not find a significant link between COVID-19 vaccination and the risk of NICU admission or the SGA.
-
-
-
A Mini Review on Effect of Corona Virus on Cancer Related to Lungs
Authors: Ujjwal Chauhan, Nitesh Kumar, Arshdeep Chopra, Yash Sharma, Ajay Pal Singh, P.K Sharma and MahimaAvailable online: 30 December 2024More LessThe emergence of the COVID-19 pandemic, caused by the SARS-CoV-2 virus, has significantly impacted cancer patients, particularly those with lung cancer. This review delves into the intersection of COVID-19 and lung cancer, addressing concerns regarding diagnosis, treatment, and outcomes. Research demonstrates that patient co-factors, including age, sex, blood type, and knowledge levels, are strongly associated with the severity and mortality of COVID-19 in lung cancer patients. Older age, male gender, and specific blood types correlate with worse results. Cancer patients, already immunocompromised, face heightened risks from COVID-19, with increased morbidity and mortality rates. The pandemic has necessitated rapid adjustments in oncological care, including telemedicine and altered treatment protocols. Vaccination tactics are essential, with effectiveness differing based on whether patients have gotten the initial dosage, second dose, or booster doses. Various vaccination forms, including mRNA vaccines, viral vector vaccines, and inactivated virus vaccines, have differing effectiveness profiles, particularly in immunocompromised persons. Booster dosages have shown improved immunity against developing variations such as Delta and Omicron. Lung cancer, the second most diagnosed cancer globally, presents diverse challenges due to its association with smoking and exposure to environmental carcinogens. Diagnosis relies on histological confirmation, with treatment decisions guided by disease staging and molecular profiling. Innovative diagnostic tools, such as molecular markers and genetic sequencing, enhance personalized treatment approaches. The pandemic's impact on cancer diagnosis and treatment pathways underscores the need for vigilant surveillance and adaptive strategies to ensure optimal patient care. This abstract encapsulates the critical considerations and evolving landscape of managing COVID-19 and lung cancer, emphasizing the importance of tailored approaches in navigating these intertwined health crises. The abstract summarizes the diagnostic and management approaches for lung cancer and COVID-19, highlighting key methods such as radiographic screening, liquid biopsy, sputum examination, and nucleic acid amplification tests for diagnosis. Treatment strategies for both conditions are discussed, emphasizing the challenges faced by lung cancer patients, particularly in the context of COVID-19 infections. The abstract also addresses the importance of early detection through biomarker discovery and the development of new therapies tailored to individual patients. Furthermore, prognostic and predictive biomarkers for lung cancer are identified, such as EGFR mutations and ALK rearrangements, which inform treatment decisions. The abstract underscores the need for comprehensive care strategies that consider the intersection of lung cancer and COVID-19, ensuring optimal outcomes for affected patients. Ultimately, care strategies must take consideration of patient co-factors like age, sex, blood group, and knowledge levels, as well as vaccine administration schedules like first doses, second doses, and booster shots and vaccine type reflections. The overall strategy aims to improve treatment and immunization efficacy, improving lung cancer outcomes during the COVID-19 pandemic.
-
-
-
Neurofunctional Impacts of COVID-19: Memory Loss and Cognitive Decline and Treatment
Available online: 27 December 2024More LessAlthough SARS-CoV-2, the virus that causes COVID-19 has been responsible for pneumonia, recent studies indicate that it also affects the kidneys, heart, and brain, among other vital organs. Evidence suggests that this virus may travel retrogradely from the olfactory epithelium to brain stem sections, causing neurological impairments in a significant number of individuals. Individuals with severe COVID-19 frequently have elevated cytokines that promote inflammation and acute respiratory failure and require frequent supportive ventilation. These factors are believed to contribute to cognitive deterioration. Severe neurological outcomes in COVID-19 patients include- paralysis, stroke, cranial nerve deficits, delirium, encephalopathy, seizures, and meningitis. The virus, with its unique structure, and a high binding affinity for the human enzyme ACE2 (used as an entry point by the virus), contributes significantly to its deadly nature. Furthermore, to address the outbreak effectively, researchers worldwide must develop precise treatment strategies. Advancing new diagnostic and treatment methods to mitigate the long-term effects of COVID-19 on cognition requires further epidemiological research and clinical experience. Additionally, by understanding the virus's impact on cognitive functions, healthcare professionals can develop targeted treatments to alleviate these severe neurological consequences.
-
-
-
Knowledge, Attitude, and Practice of Novel Coronavirus (COVID-19) Among Young Adults in Iraq
Available online: 27 December 2024More LessBackgroundSociety's information regarding practices, attitudes, and knowledge influences the society's behaviors and practices toward COVID-19 and affects preventive measures and disease control.
AimThis study aims to assess the knowledge, attitude, and practices towards COVID-19 in the young adults of the Iraqi general population.
Materials and MethodsCross-sectional study web-based survey conducted between 30th September 2023 to 31st January 2024. The data was gathered through an electronic questionnaire. The survey was conducted in the Iraqi population and included male and female participants aged ≥ 18 years. A self-administered structured questionnaire was used for data gathering. The questionnaire consists of items to get information from the participants: risk factors, knowledge, attitudes and practices toward SARS-CoV-2 infection, and social and demographic characteristics. An Arabic version of the questionnaire was prepared. The questionnaire consists of the knowledge part, which includes 11 questions, while attitudes include 10 questions and practices include 8 questions. The knowledge was evaluated on the basis of the correct answer and converted to a score of 5. While for the attitudes, a 5-point Likert-type scoring system was created for responses (1- strongly disagree; 2- disagree; 3-neutral; 4- agree; 5- strongly agree). For the practices, a 5-point Likert score is used for response evaluation (5- always; 4- often; 3- sometimes; 2- rarely; 1-never). The questionnaire link was sent online to the participants via Facebook, Instagram, Telegram, and WhatsApp. The questionnaire participants replied in the Microsoft Excel sheet. An ANOVA test was used to determine the differences in significance between the KAP items and within the section of each KAP. Post-hoc test used for analysis of significance between K and A, K and P, A and P. The significance of the differences between groups was determined using the chi-square test. The analysis was performed using SPSS version 20.
ResultsThere were 1484 participants, with a survey response rate of 86.7% (1484/1712). The majority of the participants (69.3%) were in the age group of 18 to 25 years, and 85.9% of them were B.Sc., M.Sc., Ph.D., and college students. 90.5% were from urban areas, and 27.6% participated in an online course for COVID-19. The mean score of knowledge was 3.04 ± 0.84, which means that the mean correct answer of the knowledge item was 61%. The highest correctly answered question (87%) was regarding the preventive measures for COVID-19 infection, followed by the main symptoms of COVID-19 (76.5%). The lowest correctly answered question (27%) was regarding the mortality rate of COVID-19, followed by complications of COVID-19 (38.1%). The total knowledge mean score was 61% of the scale (score 3.04/5), and this indicated that 61% of the population has good knowledge regarding the COVID-19 pandemic. Additionally, there were high significance (p < 0.01) differences between the knowledge item score and the correct answer. A post-hoc test indicated a significant difference (p = 0.0305) in item scores between knowledge and practices, but there was no significant difference between knowledge versus attitudes or between attitudes versus practices. Attitudes mean score was 3.6 and 72% frequency of correct answers for the items. A significant number of participants expressed worry about themselves, their family members, friends, or society (64.8%) getting infected. Thus, about 1/3 of the participants were not worried about getting an infection. However, 18.4% of participants did not express any as they gave a neutral answer. It is interesting that 80.3% of the participants believed that an asymptomatic patient could transmit the virus to others. The survey indicated a rate with an average of 12.5% to 36% of neutral responses to the addressed questions. The mean score of practice was 9.98 and the correct answer frequency was 79.6%. The majority of participants (83.3%) reported an acceptable practice. Individual questions were answered correctly in a range of 88.1% to 94.7%, with the exception of carefully removing PPE and discarding it in the proper place (17.1%).
ConclusionsThe young adults Iraqi general population had a good KAP standard. Attitudes and practice scores were higher than those of knowledge. The knowledge score mean value was 3.04 and the correct answers frequency was 61%, with the items score range of 1.4 and 4.4, while the correct answers frequency range was 27% and 87%. The mean score of attitudes was 3.6 with a range of 2.8–4.2, while the correct mean frequency was 72% with a range of 56% to 84%. The mean score of practices was 3.98 with a range of 1.6 to 4.5, while the mean frequency of the correct answer was 79.6% with a range of 32% to 90%.
-
-
-
Investigating the Level of Knowledge of Nurses Working in Educational Hospitals of Ilam about COVID-19 in Iran
Authors: Masoumeh Shohani, Mohamadreza Kafashian and Hamed TavanAvailable online: 23 December 2024More LessIntroductionSince nurses are responsible for caring of patients, increasing their knowledge will lead to better care. Here, we measured nurses’ COVID-19 knowledge in the teaching hospitals of Ilam.
Materials and MethodsIn this study, descriptive-analytical approach was used for data collection using a self-assessment questionnaire including demographic information and 12 questions about nurses' knowledge of COVID-19 disease. The data were collected in May 2020 and analyzed by SPSS 19 software. The significance level was considered at P <0.05.
ResultsOverall, 134 (72.4%) and 51 (27.6%) of the participants were males and females, respectively. The mean score of knowledge about COVID-19 disease was 6.04± 0.45. Nearly half of the nurses (45.4%) had good knowledge on the source of the disease, signs and symptoms, transmission routes, and progression and mortality rate of COVID-19.
ConclusionMost of the nurses had intermediate knowledge about COVID-19. However, it is essential for the Ministry of Health to provide accurate and coherent information according to the WHO guidelines.
-
-
-
Outbreak Transmission of Coronavirus- A Case Study
Available online: 23 December 2024More LessIntroductionThe COVID-19 pandemic, originating in Wuhan, China, swiftly spread globally, wreaking havoc on both personal lives and economic stability.
MethodIts highly contagious nature, transmitted through human contact, necessitated urgent government interventions worldwide. Measures such as quarantine, social distancing, and lockdowns, alongside medical awareness campaigns, were earnestly adopted to mitigate its impact.
ResultsWhile the development of a cure remains a time- consuming endeavor, the focus has shifted towards prevention through diverse strategies, explored in this study.
ConclusionPresenting a stochastic model, this paper aims to analyze the percentage of affected individuals across various factors, highlighting the efficacy of lockdown measures at different intervals.
-
-
-
SARS CoV-2 Delta Variant Spike Protein: Structure, Mechanism, and Docking Interaction with Antiviral Ligands from the Plants of the Phyllanthus Genus
Available online: 16 December 2024More LessAn abrupt outbreak of “Severe Acute Respiratory Syndrome Coronavirus 2” was first identified in Wuhan City, Hubei Province, China, in December 2019, which was later disseminated globally. Individuals afflicted with this highly transmissible virus contribute to a significant public health crisis. The lack of specific vaccinations and antiviral medications for nCoV-2019, together with the emergence of mutations in the genome of the virus, necessitates a multifaceted approach to drug design and discovery for COVID-19. A comprehensive worldwide supervision plan is essential for the accurate forecast and prevention of viral infections. The SARS-CoV-2 spike (S) protein plays a crucial role in viral binding, fusion, and entrance, hence influencing the generation and evolution of antibodies and vaccines. The receptor binding domain (RBD) of the SARS-CoV-2 spike protein exhibits a significant affinity for human angiotensin-converting enzyme 2 (ACE2) receptors. It encompasses diverse mutations in the N-terminal domain (NTD) and the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein, enhancing immunological efficacy. The B.1.617.2 mutant, also known as the Delta variation, is expected to spread more rapidly than earlier versions. Thus, in this study, we have evaluated the structural characteristics of the SARS-CoV-2 spike protein and the human ACE2 protein and their interactions and examined putative SPIKE-ACE2 protein-protein inhibitors derived from the phytocompounds of Phyllanthus species. This is the crucial aspect for the advancement of economical clinical trials of individual plant components for the treatment of viral diseases.
-
-
-
The Impact of Diabetes-related Factors on the Severity and Outcome of COVID-19 Infection in Hospitalized Patients: A Descriptive-analytical Study
Available online: 16 December 2024More LessIntroductionThe COVID-19 pandemic is having a devastating impact on public health, with a higher risk of severe illness and mortality in vulnerable groups. Individuals with a history of diabetes are more prone to severe COVID-19. A collection of hyperglycemia, inflammation, and impaired immunity in diabetes, especially in poor glycemic control, notably increases the risk of COVID-19 severity. Hyperglycemia can trigger the release of inflammatory cytokines, highlighting the intricate relationship between glucose metabolism and inflammation, and contributing to cytokine storms that worsen COVID-19 severity. Understanding this relationship enables healthcare providers to develop personalized care strategies for managing blood glucose in diabetic patients, thereby reducing the risk of severe COVID-19 outcomes. This study aims to identify the factors that contribute to the severe outcomes of COVID-19 in patients with diabetes, to better understand and manage this critical combination.
MethodsA total of 411 patients with COVID-19 infection referred to the Teaching Hospital of Mazandaran University of Medical Sciences, Sari, were included in this study. The COVID-19 severity was evaluated according to the World Health Organization (WHO) guidelines. All information including demographic, clinical, and laboratory data as well as severity and outcome of the disease were compared between diabetic and non-diabetic patients.
ResultsThe diabetic patients had higher blood glucose (210.3 ±114.9 mg/dl) compared to non-diabetics (118.74 ±3.8 mg/dl) upon admission (p=0.0001). Diabetics also experienced more severe COVID-19 infection (p=0.048). Patients with severe COVID-19 had significantly higher blood glucose (168.5 ±12.8 mg/dl) than those with non-severe infection (136.6± 6.3 mg/dl) (p=0.013). Diabetics had higher erythrocyte sedimentation rates (ESR) compared to non-diabetics (52.25±2.4 vs. 43.81±1.8 mm/h, p=0.006). Diabetic patients taking ACEIs/ARBs had more severe COVID-19 infection (p=0.031).
ConclusionThe study discovered a positive relationship between hyperglycemia and COVID-19 severity, as well as a higher risk of severe COVID-19 among patients taking ACEIs or ARBs.
-
-
-
The XEC COVID-19 Variant: A Global Threat Demanding Immediate Action
Authors: Afzal Hussain, Ashfaq Hussain, Walid A. H. Eldaif and Mohammad RashidAvailable online: 16 December 2024More LessThe new XEC variant that has recently been described, a recombinant strain originated from the Omicron sub-lineages KS1.1 and KP3.3 (also known as FLuQE; it is descended from the FLiRT lineage), has since early July, 2024, been confirmed in more than 15 EU countries as well as North America and Asia. Currently, the XEC variant is reported in 27 countries, including America, Britain, and China, with T22N and Q493E in the spike that gives it a transmission advantage, meaning that it may be the dominant strain in this coming winter season. Like past COVID-19 strains, XEC has caused flu-like signs, including fever, sore throat, and body aches. Thus, the high efficacy of vaccines in preventing severe disease and hospitalization cannot negate the necessity to pay attention to XEC, increase public health measures, and improve genomic surveillance due to the high transmissibility of the virus and slight advantage in transmission. This letter urges people worldwide to pay attention to how XEC is spreading and to act quickly to stop new cases from rising, especially among the susceptible groups.
-
-
-
The Severity of Disease and Hospital Length of Stay for the First and Second Admission of COVID-19 Patients: An Observational Study from Southeastern Iran
Available online: 13 December 2024More LessBackgroundThis study aimed to investigate the severity of disease and length of hospital stay for COVID-19 patients admitted to a hospital in southeastern Iran.
MethodThis cross-sectional study was conducted in Kerman, Iran. Data were collected from patients who visited Afzalipour Hospital in Kerman more than twice during the COVID-19 epidemic from the end of February 2020 to March 21, 2021. We conducted two key analyses: 1. Mixed effect logistic regression was used to check the relationship between the variables and COVID-19 severity. 2. Mixed effect linear regression was used to check the relationship between the variables and the length of stay in the hospital.
ResultsThe findings indicated that the most important risk factors for the severity of COVID-19 were heart diseases (OR=1.67,95%CI:1.20-2.30), increasing age (OR=2.23 for age>54, 95%CI:1.70-2.90), male gender (OR=1.47,95%CI:1.10-1.96), respiratory diseases other than asthma, and frequency of admission (OR=1.60,95%CI:1.20-2.15). All patients who underwent readmission experienced a shorter duration of hospitalization during their subsequent admission (OR=0.94,95%CI:0.91,0.96) and had a higher mortality rate (30% within 14 days, 26.6% between 14-90 days). Patients readmitted at intervals of 14-90 days and greater than 90 days exhibited lower disease severity compared to those readmitted within the 0-14 day period.
ConclusionExamining readmissions, the severity of COVID-19, and the length of hospital stay in affected patients are important factors for planning and allocating resources for COVID-19 management and treatment. These factors can help policymakers develop effective clinical guidelines for hospitalization or outpatient treatment of COVID-19 patients and contribute to reducing the burden of disease in the community.
-
-
-
The Impact of the Coronavirus Pandemic on Telemedicine Evolution in Obstetrical Care During COVID-19
Authors: Dr Wassan Nori, Amenah Fadhil and Zainab Abdul Ameer JaafarAvailable online: 13 December 2024More LessThe COVID-19 pandemic has imposed drastic challenges to the health system and resulted in drastic measures to reduce the high morbidity and mortality rates observed among affected individuals. Pregnant women were faced with an unexpected suspension of anti-natal care with the recommendation of indoor confinement. Telemedicine (Tm), defined as the delivery of healthcare via communication, stood up as a valuable tool to address those needs with its convenience of remote monitoring and ease of use. This review aimed to verify the transition of Tm in obstetrical care, define factors and barriers associated with its acceptance, its performance, and how it evolved during the COVID-19 era to guide its role in modern obstetrics. Four electronic repositories were searched: PubMed, Scopus, WOS, and Google Scholar using the keywords (pregnant, telemedicine, COVID-19, feto-maternal health, outcome, satisfaction, and health care); eligible studies were included in the analysis. Despite the challenges and difficulties faced by Tm during its early implementation in the pandemic, its effectiveness was demonstrated. Looking back to the lessons learned from the pandemic, Tm stood out as a reliable, safe, cost-effective tool for delivering anti-natal care during lockdown. Its role in alleviating anxiety and stress associated with the pandemic was notable. There are still gaps in our knowledge that need to be researched further, practically, the long-term outcome of Tm follow-up for both the mothers and their babies, and from a lower income countries' perspective as Tm services faced digital literacy in those areas. It has been anticipated that Tm will play a crucial role in modern obstetrics, as an integral part of the health service or as a complete part. Moreover, by adopting the 2 models, pregnant women will have the leverage of to aim for better delivery and outcomes in the presented health care.
-
-
-
Investigating the Relationship Between Postpartum Depression, Antenatal Depression, Corona Disease Anxiety, and Personality Traits During the COVID-19 Pandemic
Available online: 03 December 2024More LessBackground and AimPostpartum depression has a profound impact, both physically and psychologically, on both the mother and her newborn. With a focus on the prevalent psychological complications following the onset of this condition, this study aimed to explore the correlation between antenatal depression and Corona disease anxiety, personality traits, and postpartum depression during the COVID-19 pandemic.
Materials and MethodsThis cross-sectional descriptive-analytical study investigated women receiving care at health centers affiliated with Kerman University of Medical Sciences during the last month of their pregnancy and the postpartum period in 2022. Following the acquisition of informed consent, participants were assessed using various measures, including demographic and obstetric information, the Edinburgh Postnatal Depression Scale, the Corona Disease Anxiety Scale (CDAS), and the NEO Personality Inventory-Revised during their third trimester of pregnancy. The same group of participants completed the Edinburgh Depression Scale and the Corona Disease Anxiety Scale (CDAS) 4-6 weeks after childbirth.
ResultsThere was a significant correlation between family income, unwanted pregnancy as perceived by both the mother and father, and antenatal depression. Additionally, marital satisfaction played a significant role in postpartum depression. Furthermore, antenatal depression was significantly associated with neuroticism, agreeableness, and physical symptoms related to Corona disease anxiety. Personality traits, with the exception of extroversion and conscientiousness, and various domains of Corona disease anxiety, excluding psychological symptoms, were also significantly associated with postpartum depression.
ConclusionDuring pandemics or epidemics, such as the COVID-19 outbreak, experiencing mental distress during pregnancy can contribute to mental health issues during the postpartum period. This risk is particularly true in individuals with unique personality traits, emphasizing the need for increased focus on mental health within prenatal care during these crises.
-
-
-
Investigating the Relationship Between the Levels of Hematological and Biochemical Parameters of COVID-19 Patients with the Length of Hospitalization
Available online: 03 December 2024More LessBackgroundIdentifying and treating patients with COVID-19 requires the use of quick and precise laboratory diagnostic techniques that assess the patient's health and identify the illness..
AimThis study was conducted to determine the relationship between hematological and biochemical parameters and length of hospitalization in patients with COVID-19.
MethodsThis is a cross-sectional study of a descriptive-analytical type, which was conducted by census method on 360 medical records of patients with COVID-19 in Imam Khomeini Hospital in Jiroft in 2022. Data were analyzed using descriptive and inferential statistics tests.
ResultsThe average number of days of hospitalization in the present study was 4 days. The rate of COVID-19 was higher in men than in women. The most common underlying diseases in the patients were heart, pulmonary, and diabetes. Among the biochemical parameters, only lactate dehydrogenase (LDH), blood urea nitrogen (BUN), aspartate aminotransferase (AST), alanine transaminase (ALT), platelet (PLT), and erythrocyte sedimentation rate (ESR) parameters had a statistically significant relationship with the total length of hospitalization (P-value<0.001). LDH, AST, ALT, creatinine (Cr), creatine phosphokinase (CPK), blood sugar (BS), total bilirubin, and direct bilirubin parameters were higher than normal in hospitalized patients.
ConclusionThe results showed that there is a relationship between LDH, BUN, AST, ALT, PLT, and ESR parameters and the length of hospitalization of patients. The levels of LDH, AST, ALT, Cr, CPK, BS, total bilirubin, and direct bilirubin parameters in patients were higher than normal.
-
-
-
Combating Cholera in Syria: A Comprehensive Approach to Clean Water, Sanitation, and Vaccination
Authors: Komal, Priya Jindal, Sachin Joshi, Lovekesh Singh and Amandeep SinghAvailable online: 03 December 2024More LessIntroductionThis study presents a comprehensive strategy for combating cholera in Syria, with a focus on clean water initiatives, treatment, surveillance, and vaccination, and the critical role of clean water in halting disease transmission.
MethodsThe review design has involved a thorough research and review of existing literature and data on cholera outbreaks in Syria. It has also included an analysis of vaccination and treatment options, as well as an exploration of cholera surveillance systems and clean water initiatives.
ResultsKey findings have indicated that prioritizing access to clean water through community water management plans and water purification technologies is essential for cholera prevention. Case studies, supported by epidemiological data up to September 2023, have underscored the importance of clean water in stopping cholera spread.
ConclusionThe study has highlighted the urgent need for a comprehensive strategy to protect millions in Syria through enhanced water, sanitation, and vaccination measures. It has advocated for improved cholera surveillance and response systems, along with continued efforts to ensure clean water access for all.
-
-
-
Technology-based Solutions in Pandemic Era: A Deep Dive into COVID-19 Management with ChatGPT
Authors: Esmaeil Mehraeen, Niloofar Attarian, Amir Tabari and SeyedAhmad SeyedAlinaghiAvailable online: 08 November 2024More Less
-
-
-
Effects of COVID-19 on Food Supply: A Systematic Review
Available online: 01 November 2024More LessThe COVID-19 outbreak has had a significant influence on several critical industries, including agriculture, education, and the economy. This essay investigates these processes, with a focus on agriculture, where the repercussions have been particularly harsh for poor groups dealing with unpredictable food supplies and food safety.
Along with a critical examination of the shift to digital education systems, the report highlights the major obstacles that lie ahead for regions lacking adequate digital infrastructure and digital literacy. There have been notable disruptions in the economy as well. Manufacturing, the financial markets, and tourism have all seen major downturns.
The study emphasizes the crucial part that following safety measures and boosting immunization campaigns play in mitigating these negative consequences while supporting economic recovery. Also, new technical solutions have emerged throughout this time. The application of drone technology to contactless food delivery is a notable illustration of how creativity can overcome the challenges posed by the pandemic.
Finally, the report recommends the development of specific and rigorous methods to strengthen recovery efforts in these critical areas.
-
-
-
Revealing the Unseen: Post COVID-19 Biomarkers, Severity, and Outcome Mysteries
Available online: 30 October 2024More LessBackgroundAlthough the COVID-19 pandemic has passed, some patients still experience post-COVID-19 symptoms. It has been reported that COVID-19 symptoms can persist for more than three months after recovery.
ObjectiveThis study aims to analyze biomarkers, severity, and outcome factors associated with post-COVID-19 symptoms.
MethodsThis prospective cohort study involves hospitalised COVID-19 patients who were followed for up to 3 months after discharge. Clinical examinations and laboratory tests for MMP-9, TIMP-1, and IL-6 were conducted during hospitalisation and after three months.
ResultsWe enrolled 76 COVID-19 patients, with a mortality rate of 30.26%. Among them, 55 individuals (30.91%) had no residual symptoms, 54.5% had acute COVID-19, 9.09% had ongoing COVID-19, and 5.45% had long-term COVID-19. Symptomatic post-COVID-19 had oxygen demand and respiratory rates higher than no-symptoms groups. Early IL-6, IL-10, MMP-9, and TIMP-1 were lower in symptomatic post-COVID-19 compared to dead and asymptomatic post-COVID-19 groups. IL-6 and MMP-9 decrease, and TIMP-1 increases after cure. IL-6 significantly still increases in post-COVID-19 symptoms compared to no-symptoms (p=0.01). Patients more than 50 years old and critically ventilated patients are prone to have symptoms post-COVID-19.
ConclusionsMore than half of patients suffer from post-COVID-19 symptoms with various related factors. Even though IL-6 decreases after recovery, IL-6 levels are still higher in symptomatic post-COVID-19 patients.
-
-
-
Assessing the Efficacy and Challenges of Tofacitinib in the Management of COVID-19: A Systematic Review and Meta-analysis of Cohort Studies
Authors: Tahereh Dara, Mohsen Zabihi, Farahnaz Hoseinzade, Mohammad Reza Radandish, Fatemeh and SaghafiAvailable online: 29 October 2024More LessObjectivesGlobal healthcare faces challenges in combating COVID-19, with rising cases despite widespread vaccination. Severe COVID-19 cases, marked by acute respiratory distress and cytokine release syndrome, highlight the importance of managing cytokine storms. Janus kinase (JAK) inhibitors, such as tofacitinib, show promise in this regard. While tofacitinib is recommended for severe cases, challenges include adverse effects, conflicting studies, and the need for further investigation of new virus strains. Overcoming these hurdles is crucial for developing an effective treatment protocol and reducing COVID-19 mortality.
MethodsThis study conducted a comprehensive search across PubMed, Scopus, and ISI Web of Science for observational studies on tofacitinib treatment in human adults with COVID-19. The search covered a specified period up to 2024. Data extraction, including study characteristics and quality assessment, employed the Newcastle Ottawa Scale and a modified Cochrane tool. Statistical analysis, conducted with Comprehensive Meta-Analysis Software, assessed heterogeneity and significance levels.
ResultsThe meta-analysis of the three studies showed a significant reduction in mortality (Risk Ratio: 0.372, 95% CI: 0.213–0.649, P-value = 0.001) with low heterogeneity (Cochrane P-value = 0.793), while no significant reduction in the need for mechanical ventilation was observed (Cochrane P-value = 0.194).
ConclusionTofacitinib administration shows a significant reduction in COVID-19 mortality. However, the limited studies on its efficacy highlight the need for cautious interpretation in clinical assessments.
-
-
-
Evaluation of the Effect of Vaccination Status on Lung Involvement and Hospitalization in COVID-19 Patients
Authors: Ali Akin, Yılmaz Safi, Nilay Elif Bektaş and Hüseyin Avni DemirAvailable online: 22 October 2024More LessBackgroundThe spectrum of COVID-19 in adults ranges from asymptomatic infection to mild respiratory tract symptoms to severe pneumonia with acute respiratory distress syndrome (ARDS) and multiorgan dysfunction. In our study, it was aimed to investigate the effects of COVID-19 vaccine on lung involvement and hospitalization.
Materials and MethodsCases over the age of 18, who had a history of contact with cases infected with COVID-19 or had clinical findings suggestive of COVID-19, who applied to the emergency department and who were diagnosed with COVID-19 by reverse-transcriptase-polymerase chain reaction (RT-PCR) were included in the study. Age, gender, comorbid diseases, hospitalization status, thorax tomography findings, and vaccination status in the last 3 months of the patients included in the study were obtained by examining the hospital information system and patient files.
ResultsOur study included 496 patients. One hundred eighty-three of the cases were vaccinated and 42.6% (n = 78) of the vaccinated patients were male. Of the 313 unvaccinated patients, 36% (n = 113) were male. Comorbid disease was observed in 55.2% (n = 101) of the vaccinated patients and 38.7% (n = 121) of the unvaccinated patients. Of the 313 unvaccinated patients, 72.2% (n = 226) were discharged from the emergency department, 19.8% (n = 62) were admitted to the service, and 8% (n = 25) were admitted to the intensive care unit. Of the 183 vaccinated patients, 78.1% (n = 143) were discharged from the emergency department, 16.4% (n = 30) were admitted to the service, and 5.5% (n = 10) were admitted to the intensive care unit. In the vaccinated patient group, both the service admission rate and the intensive care hospitalization rate were found to be significantly lower than the non-vaccinated patient group (p < 0.05). Thoracic tomography findings of 32.9% (n = 103) of 313 unvaccinated patients were reported as CORADS 1-2-3, and thoracic tomography of the remaining 210 patients was reported as CORADS 4-5. The number of patients whose thorax tomography report was CORADS 4-5 was found to be significantly higher in the unvaccinated group than in the vaccinated group (p < 0.05).
ConclusionIn our study, it was found that vaccination significantly reduced hospitalization in COVID-19 patients. Although the mean age was higher in the vaccinated patient group, both the service admission rate and the intensive care admission rate were found to be lower.
-